Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model

BACKGROUND: Angiogenic therapy with vascular endothelial growth factor (VEGF) has been proposed as a treatment paradigm for patients suffering from an insufficiency of collateral vessels. Diabetes is associated with increase in the production of VEGF and therefore additional VEGF may not be benefici...

Descripción completa

Detalles Bibliográficos
Autores principales: Roguin, Ariel, Nitecki, Samy, Rubinstein, Irit, Nevo, Eviatar, Avivi, Aaron, Levy, Nina S, Abassi, Zaid A, Sabo, Edmond, Lache, Orit, Frank, Meira, Hoffman, Aaron, Levy, Andrew P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC320491/
https://www.ncbi.nlm.nih.gov/pubmed/14683529
http://dx.doi.org/10.1186/1475-2840-2-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC320491/
https://www.ncbi.nlm.nih.gov/pubmed/14683529
http://dx.doi.org/10.1186/1475-2840-2-18

Ejemplares similares